文献速递儿童青少年精神焦虑、强迫与应激相关障碍心境障碍

跨诊断认知行为心理治疗对常见精神健康问题青少年的疗效:一项随机临床试验

Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该务实、多中心随机临床试验在丹麦4个市镇纳入396名6至16岁、有焦虑、抑郁症状和/或行为紊乱但未达精神卫生服务转诊阈值的求助青少年,比较跨诊断CBT项目(Mind My Mind)与常规管理(MAU)的疗效。第18周时MMM组父母报告的SDQ影响量表评分降幅大于MAU组,组间差异1.10(95%CI 0.75-1.45;P<.001;Cohen d=0.60),应答者比例更高(73.1% vs 46.7%),NNT为4(95%CI 3-6),除学校出勤外获益维持至第26周。

要点

  • MMM组第18周SDQ影响评分降低2.34分,MAU组降低1.23分,组间差异1.10(95%CI 0.75-1.45;P<.001)。
  • MMM组应答者144/197(73.1%),MAU组93/199(46.7%),NNT为4(95%CI 3-6)。
  • 焦虑、抑郁症状、日常功能、学校出勤及主要问题等次要结局均显示显著获益,除学校出勤外维持至第26周。

核心结论

  • 在社区环境中,可扩展的跨诊断认知行为干预MMM在多个临床相关领域优于常规管理。

研究设计与样本

  • 务实、多中心随机临床试验,2017年9月7日至2019年8月28日在丹麦4个市镇开展,纳入396名6至16岁求助青少年,按1:1随机分配至MMM组(n=197)或MAU组(n=199)。

主要发现

  • 第18周SDQ影响评分MMM组降低2.34分,MAU组降低1.23分,初始评分分别为4.12和4.21,组间差异1.10(95%CI 0.75-1.45;P<.001;Cohen d=0.60)。
  • MMM组应答者(SDQ影响评分降低≥1分)为144/197(73.1%),MAU组为93/199(46.7%),NNT为4(95%CI 3-6)。
  • 次要结局显示父母报告的焦虑、抑郁症状、日常功能、学校出勤及主要问题变化均显著获益。
  • 除学校出勤外,所有获益维持至第26周。

关键数值与推荐

  • MMM干预为9至13次每周一次、个体化调整的手册化CBT session,由当地心理师实施;MAU组接受2次护理协调访视以增强常规照护。
  • 主要结局为第18周父母报告的SDQ影响量表评分变化(范围0-10分,分数越高表示痛苦和功能损害越严重)。

临床怎么用

  • 对于未达精神卫生服务转诊阈值、有焦虑、抑郁症状和/或行为紊乱的6至16岁青少年,可考虑提供跨诊断CBT项目MMM以改善多个临床相关结局。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Behavioral therapy and cognitive-behavioral therapy (CBT) programs targeting a single class of problems have not been widely implemented. The population of youths with common mental health problems is markedly undertreated. OBJECTIVE: To determine the effectiveness of a new transdiagnostic CBT program (Mind My Mind [MMM]) compared with management as usual (MAU) in youths with emotional and behavioral problems below the threshold for referral to mental health care. DESIGN, SETTING, AND PARTICIPANTS: This pragmatic, multisite, randomized clinical trial of MMM vs MAU was conducted from September 7, 2017, to August 28, 2019, including 8 weeks of postintervention follow-up, in 4 municipalities in Denmark. Consecutive help-seeking youths were randomized (1:1) to the MMM or the MAU group. Main inclusion criteria were age 6 to 16 years and anxiety, depressive symptoms, and/or behavioral disturbances as a primary problem. Data were analyzed from August 12 to October 25, 2019. INTERVENTIONS: The MMM intervention consisted of 9 to 13 weekly, individually adapted sessions of manualized CBT delivered by local psychologists. The MAU group received 2 care coordination visits to enhance usual care. MAIN OUTCOMES AND MEASURES: The primary outcome was change in mental health problems reported by parents at week 18, using the Strengths and Difficulties Questionnaire (SDQ) Impact scale (range, 0-10 points, with higher scores indicating greater severity of distress and impairment). Primary and secondary outcomes were assessed in the intention-to-treat population at week 18. Maintenance effects were assessed at week 26. RESULTS: A total of 396 youths (mean [SD] age, 10.3 [2.4] years; 206 [52.0%] boys) were randomized to MMM (n = 197) or MAU (n = 199), with primary outcome data available in 177 (89.8%) and 167 (83.9%), respectively, at 18 weeks. The SDQ Impact score decreased by 2.34 points with MMM and 1.23 with MAU, from initial scores of 4.12 and 4.21, respectively (between-group difference, 1.10 [95% CI, 0.75-1.45]; P < .001; Cohen d = 0.60). Number of responders (≥1-point reduction in SDQ Impact score) was greater with MMM than with MAU (144 of 197 [73.1%] vs 93 of 199 [46.7%]; number needed to treat, 4 [95% CI, 3-6]). Secondary outcomes indicated statistically significant benefits in parent-reported changes of anxiety, depressive symptoms, daily functioning, school attendance, and the principal problem. All benefits were maintained at week 26 except for school attendance. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, the scalable transdiagnostic cognitive-behavioral intervention MMM outperformed MAU in a community setting on multiple, clinically relevant domains in youth with emotional and behavioral problems. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03535805.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Jeppesen P, Wolf RT, Nielsen SM, et al. Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems: A Randomized Clinical Trial. JAMA Psychiatry. 2021. PMID: 33355633. doi:10.1001/jamapsychiatry.2020.4045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。